{
    "2021-08-05": [
        [
            {
                "time": "",
                "original_text": "恒瑞医药：新技术平台、多治疗领域布局 国际化进程可期",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "新技术平台",
                        "多治疗领域",
                        "国际化进程"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药HR19003贴剂获临试批准",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "HR19003",
                        "贴剂",
                        "临试批准"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "恒瑞市值年内缩水四成，63岁孙飘扬被迫再出山",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "市值缩水",
                        "孙飘扬",
                        "出山"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "产经报道 | 恒瑞医药：行业竞争加剧，没人能够“躺平”",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "行业竞争",
                        "加剧",
                        "躺平"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2021年8月投资策略：布局业绩确定 估值合理标的",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "业绩确定",
                        "估值合理"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "人民金融·创新药指数涨0.97% | 首个狂犬单抗药要来了，第五款国产PD-1获批上市",
                "features": {
                    "keywords": [
                        "创新药指数",
                        "狂犬单抗药",
                        "国产PD-1",
                        "获批上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药官宣新董事长！多家知名药企高层变动",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "新董事长",
                        "药企高层变动"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "爱徒难担大任，“药神”孙飘扬被迫出山",
                "features": {
                    "keywords": [
                        "孙飘扬",
                        "药神",
                        "被迫出山"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "A股融资融券日报：两融余额增加114.45亿元（8月4日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "增加"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药申报第5款ADC新药",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "ADC新药",
                        "申报"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "新能源满屏涨停，游资且战且退，北上资金却默默加仓“老白马”",
                "features": {
                    "keywords": [
                        "新能源",
                        "涨停",
                        "游资",
                        "北上资金",
                        "老白马"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}